Operating Margin of NovoCure Ltd from 31 Dec 2016 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
NovoCure Ltd quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 30 Sep 2025.
  • NovoCure Ltd Operating Margin for the quarter ending 30 Sep 2025 was -28%, a 0.04% decline year-over-year.
  • NovoCure Ltd annual Operating Margin for 2024 was -28%, a 38% increase from 2023.
  • NovoCure Ltd annual Operating Margin for 2023 was -46%, a 175% decline from 2022.
  • NovoCure Ltd annual Operating Margin for 2022 was -17%, a 101% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

NovoCure Ltd Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -28% -0.01% -0.04% 01 Jul 2025 30 Sep 2025
Q2 2025 -27% +6.2% +19% 01 Apr 2025 30 Jun 2025
Q1 2025 -27% +14% +34% 01 Jan 2025 31 Mar 2025
Q4 2024 -28% +18% +38% 01 Oct 2024 31 Dec 2024
Q3 2024 -28% +17% +38% 01 Jul 2024 30 Sep 2024
Q2 2024 -34% +3.9% +10% 01 Apr 2024 30 Jun 2024
Q1 2024 -41% -12% -43% 01 Jan 2024 31 Mar 2024
Q4 2023 -46% -29% -175% 01 Oct 2023 31 Dec 2023
Q3 2023 -44% -32% -245% 01 Jul 2023 30 Sep 2023
Q2 2023 -38% -28% -280% 01 Apr 2023 30 Jun 2023
Q1 2023 -29% -20% -240% 01 Jan 2023 31 Mar 2023
Q4 2022 -17% -8.4% -101% 01 Oct 2022 31 Dec 2022
Q3 2022 -13% -11% -696% 01 Jul 2022 30 Sep 2022
Q2 2022 -9.9% -13% -466% 01 Apr 2022 30 Jun 2022
Q1 2022 -8.4% -15% -231% 01 Jan 2022 31 Mar 2022
Q4 2021 -8.3% -14% -235% 01 Oct 2021 31 Dec 2021
Q3 2021 -1.6% -5.7% -140% 01 Jul 2021 30 Sep 2021
Q2 2021 2.7% +0.92% +52% 01 Apr 2021 30 Jun 2021
Q1 2021 6.4% +5.9% +1231% 01 Jan 2021 31 Mar 2021
Q4 2020 6.2% +6.4% 01 Oct 2020 31 Dec 2020
Q3 2020 4.1% +7.1% 01 Jul 2020 30 Sep 2020
Q2 2020 1.8% +8.2% 01 Apr 2020 30 Jun 2020
Q1 2020 0.48% +11% 01 Jan 2020 31 Mar 2020
Q4 2019 -0.26% +13% +98% 01 Oct 2019 31 Dec 2019
Q3 2019 -3% +9.7% +76% 01 Jul 2019 30 Sep 2019
Q2 2019 -6.4% +7.5% +54% 01 Apr 2019 30 Jun 2019
Q1 2019 -10% +9.8% +49% 01 Jan 2019 31 Mar 2019
Q4 2018 -14% +8.6% +39% 01 Oct 2018 31 Dec 2018
Q3 2018 -13% +22% +63% 01 Jul 2018 30 Sep 2018
Q2 2018 -14% +46% +77% 01 Apr 2018 30 Jun 2018
Q1 2018 -20% +73% +78% 01 Jan 2018 31 Mar 2018
Q4 2017 -22% +117% +84% 01 Oct 2017 31 Dec 2017
Q3 2017 -34% 01 Jul 2017 30 Sep 2017
Q2 2017 -60% 01 Apr 2017 30 Jun 2017
Q1 2017 -92% 01 Jan 2017 31 Mar 2017
Q4 2016 -139% 01 Oct 2016 31 Dec 2016

NovoCure Ltd Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -28% +18% +38% 01 Jan 2024 31 Dec 2024
2023 -46% -29% -175% 01 Jan 2023 31 Dec 2023
2022 -17% -8.4% -101% 01 Jan 2022 31 Dec 2022
2021 -8.3% -14% -235% 01 Jan 2021 31 Dec 2021
2020 6.2% +6.4% 01 Jan 2020 31 Dec 2020
2019 -0.26% +13% +98% 01 Jan 2019 31 Dec 2019
2018 -14% +8.6% +39% 01 Jan 2018 31 Dec 2018
2017 -22% +117% +84% 01 Jan 2017 31 Dec 2017
2016 -139% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.